Sign in

CIK 0001856725

  • Emerging growth company

Rani Therapeutics Holdings, Inc.

Sign in to watch
Ticker
RANI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
863114789
Phone
+1 408-457-3700
Business address
47709 FREMONT BLVD, FREMONT, CA, 94538
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy 10% owner bought 5,255 shares at an average $3.92 ($20,626)
  10. 4 Open-market buy 10% owner bought 4,420 shares at $4.46 ($19,733)
  11. 4 Open-market buy 10% owner bought 2,040 shares at $4.81 ($9,816)
  12. 4 Open-market buy 10% owner bought 2,173 shares at $4.71 ($10,225)
  13. 4 Open-market buy 10% owner bought 8,703 shares at an average $4.59 ($39,947)
  14. 4 Open-market buy 10% owner bought 5,950 shares at an average $5.05 ($30,074)
  15. 4 Open-market buy 10% owner bought 1,850 shares at $5.37 ($9,939)
  16. 4 Open-market buy 10% owner bought 1,901 shares at $5.27 ($10,019)
  17. 4 Open-market buy 10% owner bought 4,467 shares at an average $5.47 ($24,449)
  18. 4 Open-market buy 10% owner bought 3,688 shares at an average $5.31 ($19,590)
  19. 4 Open-market buy 10% owner bought 7,551 shares at $5.14 ($38,775)
  20. 4 Open-market buy 10% owner bought 11,696 shares at an average $5.49 ($64,192)

Page 5 of 10 · 194 filings